Charlotte Maggen

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Johannes J. Duvekot

NETHERLANDS

View details

Kristel Van Calsteren

BELGIUM

View details

Rebecca C. Painter

NETHERLANDS

View details

Robert Fruscio

Associate Professor in Obstetrics and Gynecology

University of Milano-Bicocca

ITALY

View details

Thomas Tousseyn

Professor Dr. at KU Leuven

KU Leuven

BELGIUM

View details

Frédéric Amant

Antoni van Leeuwenhoek Nederlands Kanker Instituut

NETHERLANDS

View details

elyce cardonick

Professor

Cooper Medical School of Rowan University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Charlotte Maggen

Research Interests

Explore related searches

Contact this professor

Articles (15)

Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features

An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy

Impact of chemotherapy during pregnancy on fetal growth

Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls

Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls

Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies.

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period.

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome.

Association of Chemotherapy Timing in Pregnancy With Congenital Malformation.

[Formula: see text]Long-term neurodevelopmental outcome after prenatal exposure to maternal hematological malignancies with or without cytotoxic treatment.

Management of pregnancy in women with cancer.

Maternal and Neonatal Outcome after the Use of G-CSF for Cancer Treatment during Pregnancy

Data describing the poor outcome associated with a breast cancer diagnosis in the post-weaning period

Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome

Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations.

Collaborators (7)

Johannes J. Duvekot

Kristel Van Calsteren

Rebecca C. Painter

Robert Fruscio

Thomas Tousseyn

Frédéric Amant

elyce cardonick

Make your next move.